YAP1 and cancer: The Hippo pathway is a key growth control pathway, in which downstream effectors, YAP (yes‐associated protein) and TAZ (transcriptional coactivator with PDZ‐binding motif), are frequently activated in cancers driving cell proliferation and tumour survival [1, 2, 3, 4].